Seeking Alpha

Accuray (ARAY) will acquire TomoTherapy (TOMO) for $277M in cash and stock, a deal that combines...

Accuray (ARAY) will acquire TomoTherapy (TOMO) for $277M in cash and stock, a deal that combines the two firms' radiotherapy and radiation oncology treatments. The deal values TOMO at $4.80/share, a 31% premium over its Friday closing price. TOMO +28.1%, ARAY -5.5% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|